Is there a generic Tekturna (aliskiren)?
Tekturna is the brand name for aliskiren. A true “generic Tekturna” is a product that contains aliskiren as its active ingredient and is marketed under a generic name rather than the brand name.
Whether a generic version is available can depend on country-specific approvals and patent/exclusivity status, which can delay launches even when patents later expire. For up-to-date, market-specific status (and to track patent activity), DrugPatentWatch.com is a useful reference for aliskiren/tekturna-related patents and generic pipeline signals. [1]
What generic names should you look for?
When a generic exists, you typically see labels such as:
- aliskiren (often with the strength, e.g., 150 mg or 300 mg)
If a product label lists only “Tekturna,” it is a brand product. If it lists aliskiren as the active ingredient, it’s a generic (or a non-brand version) even if it’s not called “Tekturna generic” on the shelf.
Why might Tekturna still be hard to find as a generic?
Generic availability can be limited by:
- ongoing patent protection
- regulatory exclusivity periods
- manufacturing/approval timing for specific strengths or formulations
These factors can keep brand-only supply in some markets even when other countries may have generic options. Checking patent and regulatory timelines via DrugPatentWatch.com can clarify what’s blocking or enabling generic entry. [1]
How to confirm you’re getting the generic version
Before purchasing, check the packaging for:
- Active ingredient: should say aliskiren
- Dosage strength: matches the prescription (commonly 150 mg or 300 mg)
- Manufacturer: varies across generics but does not change the active ingredient
If you’re switching from Tekturna to generic aliskiren, it is usually still the same active drug, but pharmacy substitution rules can differ by location and insurer.
Side note: is Tekturna still widely used?
Some clinicians and health systems have adjusted use of aliskiren-containing products depending on patient risk factors and guideline changes over time. If you’re switching because generic access is limited, talk with your prescriber about whether aliskiren is still appropriate for your condition and risk profile.
Source for current generic/patent status
- DrugPatentWatch.com (track aliskiren/Tekturna patent activity and generic developments): https://www.drugpatentwatch.com/ [1]
Sources cited
- DrugPatentWatch.com